Security key
040334104
Aridis Pharmaceuticals, Inc. - Common Stock (ARDS)
CUSIP: 040334104
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 4,126,564
- Total 13F value
- $1,294,359
- Share change
- +242,661
- SEC-reported price per share
- $0.31
- Number of holders
- 19
- Value change
- -$1,724,919
- Number of buys
- 8
- Number of sells
- 8
- Shares outstanding
- 44,586,623
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2023
Institutions
19
Top holders
10
ARDS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Aridis Pharmaceuticals, Inc. SEC filings
Aridis Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 040334104
Recent filing periods:
Ownership snapshot
Top reported holders of ARDS - Aridis Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 4.6%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 4.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
4.6%
COMMONWEALTH EQUITY SERVICES, LLC
1.3%
VANGUARD GROUP INC
1.2%
Roumell Asset Management, LLC
1%
GEODE CAPITAL MANAGEMENT, LLC
0.32%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
4.6%
|
$2,440,240
2,068,000 shares
|
— | 31 Dec 2022 |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
Company
|
1.3%
|
$678,000
575,000 shares
|
— | 31 Dec 2022 |
| VANGUARD GROUP INC |
13F
Company
|
1.2%
|
$618,854
524,453 shares
|
— | 31 Dec 2022 |
| Roumell Asset Management, LLC |
13F
Company
|
1%
|
$526,974
446,588 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.32%
|
$168,000
143,034 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
0.1%
|
$51,031
43,247 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
4,126,564
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
17
Q1 2023 holders
19
Holder diff
2
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend